• Loading stock data…

Articles

Humacyte Announces Presentations by Ukrainian Surgeons on Use of the Human Acellular Vessel(TM) to Treat Wartime Vascular Trauma at the European Society for Vascular Surgery Annual Meeting

DURHAM, N.C., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues, … [Read more...] about Humacyte Announces Presentations by Ukrainian Surgeons on Use of the Human Acellular Vessel(TM) to Treat Wartime Vascular Trauma at the European Society for Vascular Surgery Annual Meeting

Belite Bio Announces Late-Breaking Presentation at the American Academy of Ophthalmology 2022 Annual Meeting

1-year interim data from the 2-year Phase 1b/2 trial of LBS-008 in adolescent STGD1 to be presented SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a San Diego based … [Read more...] about Belite Bio Announces Late-Breaking Presentation at the American Academy of Ophthalmology 2022 Annual Meeting